With the outbreak of Mpox in several countries, the demand for vaccines has increased. The vaccine, administered as a 2-dose ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

Youngsters have been especially impacted by mpox outbreaks raging in Africa, with children under five accounting for nearly a ...

The African health agency says that Rwanda has started a vaccination campaign against mpox with 1,000 doses it obtained from ...

Mpox vaccines have been administered in Africa for the first time, with several hundred high-risk individuals vaccinated in ...

(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II ...

The Vaccine Alliance, Gavi, has announced an agreement with Bavarian Nordic to secure 500,000 doses of the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) mpox vaccine for Africa in 2024. This comes ...

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

(AP Photo/Moses Sawasawa, File) FILE - Officials check Mpox vaccine MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, at the airport in Kinshasa, Congo, Sept. 5, 2024. (AP Photo/Samy ...

However, only a few doses have reached Africa despite pleas from its governments. MVA-BN vaccine has already been used in Europe and the United States, the E.U. said, and it is authorized for use ...

4, 2024. (AP Photo/Moses Sawasawa) Mpox vaccine MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, are offloaded from a plane in Kinshasa, Congo, Thursday, Sept. 5, 2024.

The 100,000 doses of the MVA-BN vaccine, manufactured by the Danish company Bavarian Nordic, have been donated by the European Union through HERA, the bloc's agency for health emergencies.